Author Correction: Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle

Correction to: Acta Pharmacologica Sinica 10.1038/s41401-021-00752-y, published online 25 August 2021

During our recent check of our published article entitled “Benzimidazoles induce concurrent apoptosis and pyroptosis of human glioblastoma cells via arresting cell cycle” in Acta Pharmacologica Sinica, we found that there were two mistakes in Fig. 2f and 7f. The authors apologized that the representative images of Edu experiment in U87-Fenbendazole-0.25 μmol/l group (Fig. 2f, right) appeared incorrectly, which presented the same accidentally with the U87-Mebendazole-0.25 μmol/l group. The correct images are presented. Besides, the statistics of apoptosis rate in Z-VAD-FMK of U87 cells (Fig. 7f) was wrongly marked, which was marked the same as the control group. It has been corrected now. The authors declare that these corrections do not change the results or conclusions of this paper. The authors apologize for any inconvenience caused to the journal and readers.Fig. 2 f Benzimidazoles inhibited DNA synthesis (EdU assay) in U87 cells at 24 h. Scale bar = 100 μm.Fig. 7 f Z-VAD-FMK blocked flubendazole-induced apoptosis and pyroptosis in U87 and U251 cells.